Hyogo, Japan – April 25, 2025 – JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that its Board of Directors resolved at a meeting held today to nominate the following candidates for new audit & supervisory board members, to be proposed for election at the Ordinary General Meeting of Shareholders scheduled to be held on June 25, 2025. Appointments will be subject to approval at the Ordinary General Meeting of Shareholders.
Download PDF below to read full announcement.